0001209191-15-069055.txt : 20150902 0001209191-15-069055.hdr.sgml : 20150902 20150902160545 ACCESSION NUMBER: 0001209191-15-069055 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150831 FILED AS OF DATE: 20150902 DATE AS OF CHANGE: 20150902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCEPT INC CENTRAL INDEX KEY: 0001044378 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 330757995 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5810 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-320-8200 MAIL ADDRESS: STREET 1: 5810 NANCY RIDGE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FOLETTA MARK G CENTRAL INDEX KEY: 0001236389 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36284 FILM NUMBER: 151089639 MAIL ADDRESS: STREET 1: AMYLIN PHARMACEUTICALS INC STREET 2: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-08-31 0 0001044378 BIOCEPT INC BIOC 0001236389 FOLETTA MARK G C/O BIOCEPT, INC. 5810 NANCY RIDGE DRIVE, STE 150 SAN DIEGO CA 92121 0 1 0 0 Interim CFO Employee Stock Option (right to buy) 2.01 2015-08-31 4 A 0 50000 0.00 A 2025-08-30 Common Stock 50000 50000 D The shares subject to the option shall initially be unvested and 100% of the shares shall vest upon the earlier of (i) the Issuer's employment of a full time Chief Financial Officer to replace the Reporting Person and (ii) six months from the Vesting Commencement Date (8/18/15). /s/ Mark G. Foletta 2015-09-02